Abstract
Background: Aberrant expression of circular RNA (circRNA) is involved in the occurrence of various diseases and tumor development, in which it plays a vital role, including hepatocellular carcinoma (HCC). Nevertheless, the regulation mechanism and biological function of circITCH in HCC remain unclear.
Methods: The expression level of circular RNA itchy E3 ubiquitin protein ligase (circ-ITCH) was identified and validated by real-time polymerase chain reaction (RT-qPCR) in HCC cell lines. The stability of circITCH was confirmed by Ribonuclease R (RNase R) assay. Subsequently, through silencing and overexpression of circITCH, the functional roles of circITCH in HCC proliferation, invasion, and apoptosis were investigated. Bioinformatics analysis and luciferase reporter assays were performed to define the relationship between microRNA (miR)-184 and circITCH.
Results: CircITCH (hsa_circ_0001141) was found to be a stable circRNA and was downregulated in HCC cells. Overexpression of circITCH inhibited cell proliferation, migration, and invasion and promoted apoptosis in vitro, whereas knockdown of circITCH had the opposite effects. Mechanistically, miR-184 could be sponged by circITCH, and its overexpression could mitigate the suppressive effects of circITCH overexpression on HCC progression. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to investigate mRNAs with significant functional enrichment and pathways related to HCC and immune cells.
Conclusions: Our findings reveal that circITCH serves as a repressor to restrain HCC malignancy via miR-184. Therefore, circITCH may serve as a potential prognostic marker and therapeutic target for HCC.
Introduction
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality globally, characterized by high rates of metastasis and recurrence. Recent research has highlighted the regulatory roles of circular RNAs (circRNAs)—stable, non-coding RNAs with a covalently closed-loop structure—in various malignancies. This study investigates the role of circITCH (hsa-circ-0001141) in liver cancer, exploring its potential as a prognostic marker and therapeutic target by mapping its regulatory network.
Methods
The study employed a comprehensive suite of molecular biology techniques to validate the circITCH/miR-184 axis:
- Expression & Stability: RT-qPCR was used to measure RNA levels, while RNase R digestion confirmed that circITCH is circular and more stable than linear RNA.
- Functional Assays: The team used "loss-of-function" (siRNA knockdown) and "gain-of-function" (lentiviral overexpression) experiments to observe changes in cell behavior.
- Phenotyping: Cell proliferation was measured via CCK-8 and EdU assays; migration and invasion were assessed using wound healing and Transwell assays; and apoptosis was tracked via flow cytometry.
- Mechanism Mapping: Dual-luciferase reporter assays and RNA Fluorescence In Situ Hybridization (FISH) were used to prove that circITCH physically binds to (sponges) miR-184 in the cytoplasm.
- Bioinformatics: Databases like starBase, RNAInter, and TCGA were used to predict downstream mRNA targets and perform Gene Ontology (GO) and KEGG pathway enrichment analyses.
Results
circITCH is Downregulated and Stable in HCC
The researchers found that circITCH expression was significantly lower in HCC cell lines (such as Huh7 and HCCLM3) compared to normal liver cells (LO2). Because circRNAs lack 5’ caps and 3’ tails, they are resistant to exonuclease degradation. RNase R digestion assays confirmed this inherent stability, making circITCH a robust potential biomarker.
circITCH Acts as a Tumor Suppressor
Overexpressing circITCH in HCC cells significantly inhibited their ability to multiply and migrate while promoting programmed cell death (apoptosis). Conversely, knocking down circITCH made the cells more aggressive, increasing their proliferative and invasive capacity.
The "Sponge" Mechanism: circITCH and miR-184
Mechanistic studies identified a competing endogenous RNA (ceRNA) network. circITCH acts as a "molecular sponge," sequestering the oncogenic microRNA miR-184. By binding to miR-184, circITCH prevents it from silencing target mRNAs that would otherwise suppress tumor growth. Luciferase assays confirmed a high affinity between circITCH and miR-184. Furthermore, adding miR-184 mimics to cells overexpressing circITCH reversed the tumor-suppressive effects, proving that circITCH's benefits are specifically tied to its ability to neutralize miR-184.
Discussion and Conclusion
This research establishes circITCH as a critical tumor suppressor in HCC. By sponging miR-184, circITCH modulates pathways involved in Wnt signaling, the epithelial-mesenchymal transition (EMT), and apoptosis. While these in vitro findings are significant, the authors acknowledge the need for future validation in larger clinical cohorts and in vivo animal models to confirm circITCH's therapeutic potential in a living system. Nevertheless, circITCH represents a promising prognostic marker and a potential target for future HCC therapies.
Summary updated